BIOCHEMICALLY RECURRENT PROSTATE CANCER

Clinical trials for BIOCHEMICALLY RECURRENT PROSTATE CANCER explained in plain language.

Never miss a new study

Get alerted when new BIOCHEMICALLY RECURRENT PROSTATE CANCER trials appear

Sign up with your email to follow new studies for BIOCHEMICALLY RECURRENT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Prostate cancer study tests if newer drug reduces unwanted side effects

Disease control Completed

This study compared two prostate cancer drugs, darolutamide and enzalutamide, to see if one causes fewer side effects like breast tenderness and tissue growth. Researchers tested 28 men whose prostate cancer had returned after initial treatment but hadn't spread significantly. Th…

Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CANCER

Phase: PHASE2 • Sponsor: Bayer • Aim: Disease control

Last updated Mar 18, 2026 14:41 UTC

BIOCHEMICALLY RECURRENT PROSTATE CANCER

Get alerted when new BIOCHEMICALLY RECURRENT PROSTATE CANCER trials appear

Prostate cancer study tests if newer drug reduces unwanted side effects